Plasma Protein Therapeutic Market by Product Type (Coagulation Factors, Immunoglobulin, Alpha-1 Proteinase Inhibitor, and Albumin), by Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, and Other Indications), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global plasma protein therapeutic market expected to generate revenue of around USD 31.72 billion by end of 2024, growing at a CAGR of around 7.33% between 2018 and 2024. Plasma can be defined as a clear, straw-colored fluid part of the blood which residue after red platelets, blood cells, white blood cells and other cellular components are eliminated.

03-Sep-2018 | Number of pages: 110 | Report Code: ZMR-3310 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the Plasma Protein Therapeutic Market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the Plasma Protein Therapeutic Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Plasma Protein Therapeutic Market on a global level.

In order to give the users of this report a comprehensive view of the Plasma Protein Therapeutic Market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses product type, application segmentation, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Plasma Protein Therapeutic Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the Plasma Protein Therapeutic Market by segmenting the market based on product type, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on product type, Plasma Protein Therapeutic Market has been segmented into coagulation factors, immunoglobulin, alpha-1 proteinase inhibitor, and albumin. Based on applications, Plasma Protein Therapeutic Market has been segmented into hemophilia, primary immunodeficiency disorder, idiopathic thrombocytopenic purpura, secondary immunodeficiency, hereditary angioedema, and other indications.

The growing usage of the plasma proteins derived medicines is a major driver of the market growth during the forecast period. Additionally, the introduction of new plasma-derived therapies are the major factors which drive the patient segment in Plasma Protein Therapeutic Market with the highest CAGR during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further divided into major countries including the U.S., Germany, France, the U.K., China, Japan, India, and Brazil. This segmentation includes demand for Plasma Protein Therapeutic Market based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Octapharma, CSL limited, Baxter, Telecris, Grifols, Kedrion, and Chengdu Inst. Japan Red Cross, LFB Group, Shanghai Blood Institute, BPL Group, and Sanquin are some of the nonprofit organizations that are also playing a vital role in Plasma Protein Therapeutic Market market.

This report segments the global Plasma Protein Therapeutic Market as follows:

Global Plasma Protein Therapeutic Market: By Product Type

  • Coagulation factors
  • Immunoglobulin
  • Alpha-1 proteinase inhibitor
  • Albumin

Global Plasma Protein Therapeutic Market: By Applications

  • Hemophilia
  • Primary immunodeficiency disorder
  • Idiopathic thrombocytopenic purpura
  • Secondary immunodeficiency
  • Hereditary angioedema
  • Other indications

Global Plasma Protein Therapeutic Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

Cannabis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3743 | Report Format:

Global Cannabis Market: Overview Cannabis business is rapidly gaining momentum in the recent years, owing to legalization of cannabis for medicinal use by various governments across the globe. Reportedly, the cannabis sector comprises of legal cannabis cultivators consumers, regulators, researc...Read More

Prenatal Vitamin Supplements Market by Dosage Form (Capsule, Powder, and Gummy) and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, Supermarkets, and Drug Stores): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Jan-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3741 | Report Format:

The report covers a forecast and an analysis of the prenatal vitamin supplements market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints of t...Read More

Leukapheresis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3732 | Report Format:

Global Leukapheresis Market: Overview Leukapheresisis a laboratory method in which white blood cellsare separated from a sample of blood. It is a particular kind ofapheresis, the more general term for separating out one specific constituent of blood and returning the remainder to the circulation...Read More

Bile Duct Cancer Drug Market by Type (5-fluorouracil (5-FU), Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, and Others) and by Application (Hospitals, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Jan-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3702 | Report Format:

The report covers a forecast and an analysis of the bile duct cancer drug market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD million). The study includes drivers and restraints for the bil...Read More

Overactive Bladder Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3682 | Report Format:

Global Overactive Bladder Treatment Market: Overview Overactive bladder is a common medical condition where there is a sudden urge of urination. Overactive bladder is sometimes coupled with urine leakage, a condition known as incontinence. Millions of people across the globe suffer from overacti...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.